Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice W Boehmerle, P Huehnchen, S Peruzzaro, M Balkaya, M Endres Scientific reports 4 (1), 6370, 2014 | 140 | 2014 |
Modulation of adult hippocampal neurogenesis during myelin‐directed autoimmune neuroinflammation P Huehnchen, T Prozorovski, P Klaissle, A Lesemann, J Ingwersen, ... Glia 59 (1), 132-142, 2011 | 72 | 2011 |
Assessment of paclitaxel induced sensory polyneuropathy with “Catwalk” automated gait analysis in mice P Huehnchen, W Boehmerle, M Endres PloS one 8 (10), e76772, 2013 | 64 | 2013 |
MPTP-induced hippocampal effects on serotonin, dopamine, neurotrophins, adult neurogenesis and depression-like behavior are partially influenced by fluoxetine in adult mice A Lesemann, C Reinel, P Hühnchen, M Pilhatsch, R Hellweg, P Klaissle, ... Brain research 1457, 51-69, 2012 | 64 | 2012 |
Physical activity and environmental enrichment regulate the generation of neural precursors in the adult mouse substantia nigra in a dopamine-dependent manner P Klaissle, A Lesemann, P Huehnchen, A Hermann, A Storch, B Steiner Bmc Neuroscience 13, 1-15, 2012 | 63 | 2012 |
A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice P Huehnchen, W Boehmerle, A Springer, D Freyer, M Endres Translational psychiatry 7 (8), e1185-e1185, 2017 | 62 | 2017 |
Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice W Boehmerle, H Muenzfeld, A Springer, P Huehnchen, M Endres Journal of molecular medicine 92, 889-900, 2014 | 47 | 2014 |
Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy P Huehnchen, C Schinke, N Bangemann, AD Dordevic, J Kern, ... JCI insight 7 (6), 2022 | 46 | 2022 |
Cognitive impairment after cytotoxic chemotherapy P Huehnchen, A van Kampen, W Boehmerle, M Endres Neuro-Oncology Practice 7 (1), 11-21, 2020 | 44 | 2020 |
TRPV4 inhibition prevents paclitaxel-induced neurotoxicity in preclinical models W Boehmerle, P Huehnchen, SLL Lee, C Harms, M Endres Experimental Neurology 306, 64-75, 2018 | 35 | 2018 |
Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC)-derived sensory neurons C Schinke, VF Vallone, A Ivanov, Y Peng, P Körtvelyessy, L Nolte, ... Neurobiology of disease 155, 105391, 2021 | 33 | 2021 |
Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl/6 mice P Huehnchen, H Muenzfeld, W Boehmerle, M Endres Cell death & disease 11 (1), 45, 2020 | 29 | 2020 |
Bortezomib at therapeutic doses poorly passes the blood–brain barrier and does not impair cognition P Huehnchen, A Springer, J Kern, U Kopp, S Kohler, T Alexander, ... Brain communications 2 (1), fcaa021, 2020 | 22 | 2020 |
Suramin-induced neurotoxicity: preclinical models and neuroprotective strategies D Von der Ahe, P Huehnchen, M Balkaya, S Peruzzaro, M Endres, ... Molecules 23 (2), 346, 2018 | 18 | 2018 |
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: a retrospective multicentre cohort study L Müller-Jensen, S Zierold, JM Versluis, W Boehmerle, P Huehnchen, ... European Journal of Cancer 175, 224-235, 2022 | 17 | 2022 |
Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events L Müller-Jensen, S Knauss, L Ginesta Roque, C Schinke, SK Maierhof, ... Frontiers in Immunology 14, 1108116, 2023 | 16 | 2023 |
Neurological side effects of checkpoint inhibitors S Knauss, L Ginesta Roque, P Hühnchen, L Heinzerling, W Böhmerle, ... Der Nervenarzt 90, 138-147, 2019 | 13 | 2019 |
Chemotherapy-induced neuropathy W Boehmerle, P Huehnchen, M Endres Der Nervenarzt 86, 156-160, 2015 | 13 | 2015 |
Fingolimod therapy is not effective in a mouse model of spontaneous autoimmune peripheral polyneuropathy P Huehnchen, W Boehmerle, M Endres Scientific Reports 8 (1), 5648, 2018 | 10 | 2018 |
Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial–Protocol of a multicenter, randomized, double-blind, placebo … P Huehnchen, N Bangemann, S Lischewski, S Märschenz, F Paul, ... Frontiers in medicine 9, 967964, 2022 | 7 | 2022 |